Cigarette smoke alters IL-33 expression and release in airway epithelial cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1630-1637

  Pace, Elisabetta ^a   Di Sano, Caterina ^a   Sciarrino, Serafina ^a   Scafidi, Valeria ^a   Ferraro, Maria ^a   Chiappara, Giuseppina ^a   Siena, Liboria ^a   Gangemi, Sebastiano ^b   Vitulo, Patrizio ^c   Giarratano, Antonino ^d   Gjomarkaj, Mark ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Bronchial epithelial cell; Cigarette smoke; COPD; IL 33; Inflammation

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 33; TOLL LIKE RECEPTOR 4;

ARTICLE; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; IN VITRO STUDY; INNATE IMMUNITY; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; SMOKING; ACUTE RESPIRATORY FAILURE; CYTOPLASM; LUNG CANCER;

BRONCHIAL EPITHELIAL CELL; CIGARETTE SMOKE; COPD; IL-33; INFLAMMATION;

BLOTTING, WESTERN; BRONCHI; BRONCHOALVEOLAR LAVAGE; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOENZYME TECHNIQUES; INTERLEUKINS; LIPOPOLYSACCHARIDES; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKE; TOLL-LIKE RECEPTOR 4;

EID: 84903897212     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.06.009     Document Type: Article

References (33)

1. Puchelle Edith, Zahm Jean-Marie, Tournier Jean-Marie, Coraux Christelle Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006, 3:726-733.
2. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
3. Luzina I.G., Pickering E.M., Kopach P., Kang P.H., Lockatell V., Todd N.W., Papadimitriou J.C., McKenzie A.N., Atamas S.P. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J. Immunol. 2012, 189:403-410.
4. Préfontaine D., Nadigel J., Chouiali F., Audusseau S., Semlali A., Chakir J., Martin J.G., Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 2010, 125:752-754.
5. Préfontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., Lemière C., Martin J.G., Hamid Q. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 2009, 183:5094-5103.
6. Guo Z., Wu J., Zhao J., Liu F., Chen Y., Bi L., Dong L., Liu S. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J. Asthma 2014 May 6, (Electronic publication ahead of print).
7. Savenije O.E., Mahachie John J.M., Granell R., Kerkhof M., Dijk F.N., de Jongste J.C., Smit H.A., Brunekreef B., Postma D.S., Van Steen K., Henderson J., Koppelman G.H. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J. Allergy Clin. Immunol. 2014, (pii: S0091-6749[14]00059-1). 10.1016/j.jaci.2013.12.1080.
8. Qiu C., Li Y., Li M., Li M., Liu X., McSharry C., Xu D. Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology 2013, 138:76-82.
9. Pace E., Ferraro M., Siena L., Melis M., Montalbano A.M., Johnson M., Bonsignore M.R., Bonsignore G., Gjomarkaj M. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology 2008, 124:401-411.
10. Pace E., Ferraro M., Uasuf C.G., La Grutta S., Liotta G., Giarratano A., Johnson M., Gjomarkaj M. Cilomilast counteracts the effects of cigarette smoke in innate responses of airway epithelial cells. Cell. Immunol. 2011, 268:47-53.
11. Pace E., Ferraro M., Minervini M.I., Vitulo P., Pipitone, Chiappara G., Siena L., Montalbano A.M., Johnson M., Gjomarkaj M. Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One 2012, 7:e33601.
12. Zhang L., Lu R., Zhao G., Pflugfelder S.C., Li D.Q. TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int. J. Biochem. Cell Biol. 2011, 43:1383-1391.
13. Pace E., Giarratano A., Ferraro M., Bruno A., Siena L., Mangione S., Johnson M., Gjomarkaj M. TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum. Immunol. 2011, 72:54-62.
14. Pace E., Scafidi V., Di Bona D., Siena L., Chiappara G., Ferraro M., La Grutta S., Gallina S., Speciale R., Ballacchino A., Bachert C., Bousquet J., Gjomarkaj M. Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps. Allergy 2012, 67:878-886.
15. Luppi F., Aarbiou J., van Wetering S., Rahman I., de Boer W.I., Rabe K.F., Hiemstra P.S. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir. Res. 2005, 6:140.
16. Cozens A.L., Yezzi M.J., Yamaya M., Steiger D., Wagner J.A., Garber S.S., Chin L., Simon E.M., Cutting G.R., Gardner P. A transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell Dev. Biol 1992, 28A:735-744.
17. 4. J. Immunol. 2008, 181:7292-7299.
18. Bartemes K.R., Kita H. Dynamic role of epithelium-derived cytokines in asthma. Clin. Immunol. 2012, 143:222-235.
19. Chustz R.T., Nagarkar D.R., Poposki J.A., Favoreto S., Avila P.C., Schleimer R.P., Kato A. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 2011, 45:145-153.
20. Polumuri S.K., Jayakar G.G., Shirey K.A., Roberts Z.J., Perkins D.J., Pitha P.M., Vogel S.N. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 2012, 189:50-60.
21. + T cell responses. Science 2012, 335:984-989.
22. Kakkar R., Hei H., Dobner S., Lee R.T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 2012, 287:6941-6948.
23. Zhao W., Hu Z. The enigmatic processing and secretion of interleukin-33. Cell. Mol. Immunol. 2010 Jul, 7:260-262.
24. Lefrançais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.P., Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1673-1678.
25. Lüthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., Brumatti G., Taylor R.C., Kersse K., Vandenabeele P., Lavelle E.C., Martin S.J. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
26. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., Bouche G., Girard J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. U. S. A. 2007 Jan 2, 104(1):282-287.
27. Yagami A., Orihara K., Morita H., Futamura K., Hashimoto N., Matsumoto K., Saito H., Matsuda A. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 2010, 185:5743-5750.
28. Stout-Delgado H.W., Vaughan S.E., Shirali A.C., Jaramillo R.J., Harrod K.S. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J. Immunol. 2012, 188:2815-2824.
29. Ali S., Mohs A., Thomas M., Klare J., Ross R., Schmitz M.L., Martin M.U. The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription. J. Immunol. 2011 Aug 15, 187(4):1609-1616.
30. Choi Y.S., Park J.A., Kim J., Rho S.S., Park H., Kim Y.M., Kwon Y.G. Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. Biochem. Biophys. Res. Commun. 2012, 421:305-311.
31. Küchler A.M., Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen D.R., De Angelis P.M., Scott H., Haraldsen G. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am. J. Pathol. 2008 Oct, 173(4):1229-1242.
32. Zhang Q., Wang C., Liu Z., Liu X., Han C., Cao X., Li N. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation. J. Biol. Chem. 2012 Feb 24, 287(9):6208-6217.
33. Alase A., Seltmann J., Werfel T., Wittmann M. Interleukin-33 modulates the expression of human β-defensin 2 in human primary keratinocytes and may influence the susceptibility to bacterial superinfection in acute atopic dermatitis. Br. J. Dermatol. 2012, 167:1386-1389.